Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted.Separation Agreement • March 31st, 2023 • Pear Therapeutics, Inc. • Services-health services • Massachusetts
The purpose of this letter agreement (“Agreement”) is to confirm the terms of your separation of employment from Pear Therapeutics (US), Inc. (“Pear” or the “Company”), including Pear’s offer to provide you with certain pay and benefits in exchange for your agreeing to the general release of claims and certain other commitments provided for below. This Agreement shall be effective on the eighth (8ᵗʰ) day after the date you sign it (the “Effective Date”), at which time it shall become final and binding on all parties, unless you revoke this Agreement as provided in Section 11(h). You will have until 45 days after the Separation Date to consider whether to sign this Agreement.
FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT OF June 28, 2018 University of Virginia Licensing & Ventures Group – Pear Therapeutics (US), Inc.Exclusive License Agreement • March 31st, 2023 • Pear Therapeutics, Inc. • Services-health services
This First Amendment (“First Amendment”) is made effective this [day] day of [month], 2022 (“First Amendment Date”) by and between the University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group (“UVA LVG”), a Virginia non-profit corporation having a principal place of business at 722 Preston Avenue, Suite 107, Charlottesville, Virginia 22903, and Pear Therapeutics, Inc. n/k/a Pear Therapeutics (US), Inc., (“Pear”), a Delaware for-profit corporation with offices at 200 State Street, 13th Floor, Boston, MA 02109 (each a “Party”, and collectively the “Parties”).
FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND GUARANTYCredit Agreement and Guaranty • March 31st, 2023 • Pear Therapeutics, Inc. • Services-health services • New York
This FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND GUARANTY, dated as of January 13, 2023 (this “Amendment”), is by and among PEAR THERAPETUICS, INC., a Delaware corporation (f/k/a THIMBLE POINT ACQUISITION CORP.) (“Holdings”), PEAR THERAPEUTICS (US), INC., a Delaware corporation (f/k/a PEAR THERAPEUTICS, INC.) (the “Borrower”), and PERCEPTIVE CREDIT HOLDINGS III, LP, a Delaware limited partnership, as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”) and as the Majority Lender. Reference is made to the Amended and Restated Credit Agreement and Guaranty, dated as of March 25, 2022 (as amended, supplemented or otherwise modified and in effect prior to the date hereof, the “Existing Credit Agreement”, and as further amended by this Amendment, the “Credit Agreement”), by and among the Borrower, certain subsidiaries of the Borrower from time to time party thereto, the Lenders (as defined therein) fro
